Commentary: ATP: The crucial component of secretory vesicles: Accelerated ATP/insulin exocytosis and prediabetes by Chitharanjan Duvoor et al.
GENERAL COMMENTARY
published: 02 February 2017
doi: 10.3389/fphys.2017.00053
Frontiers in Physiology | www.frontiersin.org 1 February 2017 | Volume 8 | Article 53
Edited by:
Ghanshyam Upadhyay,
City College of New York (CUNY), USA
Reviewed by:
Nagaraja Nagre,
Eastern Virginia Medical School, USA
Santosh Kumar Maurya,






These authors have contributed
equally to this work.
Specialty section:
This article was submitted to
Gastrointestinal Sciences,
a section of the journal
Frontiers in Physiology
Received: 22 July 2016
Accepted: 19 January 2017
Published: 02 February 2017
Citation:
Duvoor C, Dendi VS, Marco A,
Shekhawat NS, Chada A, Ravilla R,
Musham CK, Mirza W and
Chaudhury A (2017) Commentary:
ATP: The crucial component of
secretory vesicles: Accelerated
ATP/insulin exocytosis and
prediabetes. Front. Physiol. 8:53.
doi: 10.3389/fphys.2017.00053
Commentary: ATP: The crucial
component of secretory vesicles:
Accelerated ATP/insulin exocytosis
and prediabetes
Chitharanjan Duvoor 1, 2 †, Vijaya S. Dendi 2, 3 †, Asween Marco 2, 4 †, Nawal S. Shekhawat 2, 5 †,
Aditya Chada 2, 6, Rahul Ravilla 2, 7, Chaitanya K. Musham 2, 8, Wasique Mirza 9 and
Arun Chaudhury 2*
1Department of Endocrinology and Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA,
2GIM Foundation, Little Rock, AR, USA, 3Department of Internal Medicine and Hospital Medicine, Christus Trinity Mother
Frances Hospital, Tyler, TX, USA, 4Department of Policy, University of Arkansas for Little Rock, Little Rock, AR, USA, 5 Tutwiler
Clinic, Tutwiler, MS, USA, 6Department of Pulmonary and Critical Care Medicine, University of Arkansas for Medical Sciences,
Little Rock, AR, USA, 7Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR,
USA, 8 St. Vincent Infirmary (Catholic Health Initiative), Little Rock, AR, USA, 9 The Wright Center, Scranton, PA, USA
Keywords: exocytosis, SLC17A9, diabetes mellitus, cell secretion, ATP, purinergic
A commentary on
ATP: The crucial component of secretory vesicles
by Estévez-Herrera, J., Domínguez, N., Pardo, M. R., González-Santana, A., Westhead, E. W.,
Borges, R., et al. (2016). Proc. Natl. Acad. Sci. U.S.A. 113, E4098–E4106. doi: 10.1073/pnas.1600
690113
We are aware of concepts of osmotic and oncotic pressure in clinical physiology. Per Starling’s law,
the freely movable ions do not significantly contribute to the retention of vascular volume, or the
maintenance of interstitial fluid pressure (Jacob and Chappell, 2013). On the other hand, albumin,
due to its molecular size and inefficiency of free diffusion through the transcellular pores, assumes
a major role of maintaining oncotic pressure and retaining fluid within the vascular space. The
implications are obvious: either the lack of protein synthesis in liver diseases or loss of protein
through the leaky glomerulus in nephrotic conditions leads to deficiency of oncotic pressure, fluid
leak and its accumulation in tissue spaces.
In a recent manuscript by Estévez-Herrera et al. (2016), a relatively newly appreciated
biophysical role of ATP is elucidated. Namely, the authors provide evidence using in vitro
chromaffin cells that ATP agglomerates peptides and amines within the vesicles, thus reducing their
particle numbers and effectively reducing the osmotic pressure within the vesicles. This may be
critically important for maintaining isotonicity and survival of the vesicles in the cytosolic matrix.
ATP is a highly negatively charged molecule. It cannot simply diffuse through the membrane.
Though the existence of a vesicular nucleotide transporter (VNUT) was predicted for a long time
(Stiernet et al., 2006), the solute carrier protein SLC17A9 was only recently identified as the channel
that transports ATP through themembrane (Sawada et al., 2008). Since its discovery, several studies
have shown existence of SLC17A9 in enteric synaptic vesicles (Chaudhury et al., 2012), biliary
epithelial microvesicles (Sathe et al., 2011), in the central nervous system (Larsson et al., 2012)
and in the beta cells of the pancreas (Sakamoto et al., 2014).
In the beta cells of the pancreas, the insulin granules are not freely soluble molecules in the
cytosol but rather exists as packaged vesicles. Electron micrographs of beta cells and physiological
experiments have revealed that these insulin granules undergo regulated exocytosis to a glucose
load, rather than random secretion (Dean, 1973). Potassium-sensitive ATP channels have been
shown to play an important role for sensing of the glucose load and initiation of the exocytosis
(Rutter and Hill, 2006).
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Recently, it has been suggested that the exocytosis involving
insulin granules resembles remarkable similarity to the pattern
of inhibitory enteric neuromuscular neurotransmission
(Chaudhury, 2014). Insulin granule exocytosis involves
sequential release of ATP and the gaseous nitric oxide (NO),
which may have important regulatory roles.
The SLC17A9 channel transports ATP within the insulin
containing dense core vesicles (Sawada et al., 2008). In VNUT−/−
mice, the number and appearances of secretory granules in
islet β-cells of knockout mice were normal (Sakamoto et al.,
2014). However, insulin exocytosis was accelerated (Sakamoto
et al., 2014) The recent manuscript by Estévez-Herrera et al.
(2016) may potentially explain this significant observation. It
is well known that insulin hypersecretion is an early stage
pathophysiology which occurs in genetic obesity and prediabetes
(Gonzalez et al., 2013; Irles et al., 2015). When VNUT is absent
or deficient, ATP fails to enter the beta cells, or may load
the vesicles suboptimally (Sakamoto et al., 2014; Figure 1). The
decrease of ATP within the vesicle may alter the consistency
of the dense crystalline core of the insulin. Thus, the vesicular
osmotic pressure may be considerably elevated, leading to rapid
exocytosis. Additionally, due to the lack of insulin polymer
formation with ATP, the granular exocytosis may be sped up.
These aspects remains to be examined.
FIGURE 1 | ATP may contribute to colligative property of insulin containing vesicles (A). Note the exocytotic insulin vesicle and the dense insulin cluster in the
electron micrograph. Recent study by Estévez-Herrera et al. (2016) suggest that ATP may contribute to colligative and osmotic balance of peptide containing vesicles.
Such may be true for insulin vesicles (B). ATP and insulin colocalize in beta cells of pancreas. Scale bar, 2 µm (C). During exocytosis, both ATP and insulin are
co-released. This co-release may have wide implications as discussed in the commentary (D). In SLC17A9 knockout, the insulin containing vesicles are not altered in
number or appearance (E). In SLC17A9 knockout, the ATP and insulin contents of vesicles are decreased. But note that insulin exocytosis in SLC17A9 knockout is
accelerated. This may occur due to lack of formation of ATP-(insulin)n polymer. This rapid exocytosis is a feature of early prediabetic state, as well as seen in
progressive type II diabetes mellitus. Reproduced with permission from Sakamoto et al. (2014) and Liu et al. (2014). *Significance.
Type II diabetes mellitus is characterized by progressive
exhaustion of the beta cells of the pancreas (Butler et al.,
2016). This leads to increased insulin resistance and finally
leads to an insulin-dependent state. The rates of beta cell
damage are stochastic, and are likely multifactorial, including
the effect of ongoing treatment with anti-diabetic medications.
The ATP content in SLC17A9 knockout mice was reduced,
though not significantly (Sakamoto et al., 2014; Figure 1). It
may be remembered that insulin granule exocytosis is very
complex and may involve several protein interactors, association
with the cellular cytoskeleton, motor proteins like myosin Va,
complex spatial negotiations at the subcellular cortex and finally
the interaction with the membrane, where the dynamic pore
size may be a critical determinant of exocytosis of the insulin,
which is released either as a monomer or dimer (Ashcroft
et al., 1973; Rothman, 1994; Li et al., 1995; Sudhof, 1995;
Ivarsson et al., 2005; Braun et al., 2009; Karanauskaite et al.,
2009; Wang and Thurmond, 2009; Solimena and Speier, 2010;
Galvanovskis et al., 2011; MacDonald, 2011; Andersson et al.,
2012; Schvartz et al., 2012; Seino, 2012; Rosengren et al., 2012;
Wiseman and Thurmond, 2012; Kalwat and Thurmond, 2013;
Moghadam and Jackson, 2013; Rorsman and Braun, 2013;
Stamper and Wang, 2013; Xie et al., 2013; Bergeron et al., 2014;
Gaisano, 2014; Heaslip et al., 2014; Satoh, 2014; Sun et al., 2014;
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Hoang Do and Thorn, 2015; Rutter et al., 2015; Schumacher
et al., 2015; Takahashi, 2015; Takahashi et al., 2015; Wuttke, 2015;
Thorn et al., 2016). Some or all of these pathways may be affected
or altered in SLC17A9 channelopathy.
In this commentary, we advance the hypothesis that SLC17A9
dysfunction may contribute to the ongoing inefficacy of insulin
exocytosis, leading to progressive diabetes. The lack of entry of
ATP through a dysfunctional SLC17A9 (Sakamoto et al., 2014;
Estévez-Herrera et al., 2016) may lead to a labile insulin vesicle
formation, with enhanced rates of exocytosis. This may lead
to increased demand on the cell for further insulin biogenesis,
which may lead to a cascade of genomic stress and ultimate beta
cell death. The mechanisms involved in the rapid dissolution
of the insulin crystal before and during exocytosis, is not well-
studied. Newer methodologies may be employed to study the
insulin porosome (Jena, 2009).
What causes SLC17A9 dysfunction is not clear. Interestingly,
SLC17A9 is gated by ATP itself (Sawada et al., 2008). Thus, ATP
generation may be a limiting factor. Recent evidence suggest the
inefficiency of mitochondrial coupling function with progressive
diabetes, leading to diminished ATP production (Maechler, 2013;
Peiris et al., 2016). This may be a potential underlyingmechanism
for the SLC17A9 dysfunction. Also, the channel may be gated by
NO. NO downstream effectors are present in the beta cells and
NO is known to inhibit ATP loading of dense vesicles (Machado
et al., 2000). Using a range of biophysical methods including
dynamic light scattering, turbidimetry, circular dichroism and
atomic force microscopy, an elegant study has demonstrated
that the amino acid L-arginine (Arg) has the ability to influence
insulin aggregation propensity (Smirnova et al., 2015). The
modification of the net charge of insulin induced by increase
in the pH level of the incubation medium resulted in major
alterations clustering of Arg-insulin. Using pH markers like
pHluorin, vesicle pH may be assessed, which may serve as a
surrogate for the vesicle osmotic pressure, which is otherwise a
challenging technique to perform. Here, we may recollect that
acidification of the vesicles is the main driver of ATP entry within
the vesicles (Sawada et al., 2008).
There have been recent advances of novel markers that can tag
synaptic proteins, especially those acting on the membranes. PET
imaging may detect these global aspects of neurotransmission
(Finnema et al., 2016). It is possible that such novel imaging may
be applied for estimating beta cell mass in progressive diabetes
mellitus. This is a huge area of unmet need in diabetes mellitus
management. SLC17A9 may be tagged and imaged with similar
novel methodologies to estimate whether their quantitative
distribution is altered in progressive diabetes. Currently, C
peptide analyses is used as a crude method to estimate disease
status and functional beta cell reserve. Our thesis provides a novel
paradigm in approaching management of diabetes mellitus from
a precision medicine perspective.
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